In accordance with our hypothesis, the Cancer Genomics database shows that TLR7 mRNA expression levels are associated with better overall survival of NSCLC patients, assessed as progression free status, disease free status, and disease-specific survival status (Figure S1B). This evidence concerns the gene TLR7 and cancer.